×

Message

EU e-Privacy Directive

This website uses cookies to manage authentication, navigation, and other functions. By using our website, you agree that we can place these types of cookies on your device.

View e-Privacy Directive Documents

You have declined cookies. This decision can be reversed.

SCIENTIFIC STUDIES & BIOMEDICAL LITERATURE

Vaccinations and secondary immune thrombocytopenia with antiphospholipid antibodies by human papillomavirus vaccine.

Written by CYBERMED LIFE NEWS
Print
Abstract Title:

Vaccinations and secondary immune thrombocytopenia with antiphospholipid antibodies by human papillomavirus vaccine.

Abstract Source:

Semin Hematol. 2016 Apr ;53 Suppl 1:S48-50. Epub 2016 Apr 7. PMID: 27312165

Abstract Author(s):

Mojca Bizjak, Or Bruck, Darja Kanduc, Sonja Praprotnik, Yehuda Shoenfeld

Article Affiliation:

Mojca Bizjak

Abstract:

A 13-year-old girl developed immune thrombocytopenic purpura (ITP) and concomitant positive antiphospholipid antibodies (aPL) following vaccination with a quadrivalent human papillomavirus (HPV) vaccine. During the course of a disease, she developed clinical manifestation with bleeding and she was treated with intravenous immunoglobulins. Consequently, the number of her platelets remained critically low and she was put on corticosteroids and rituximab. Since then, her platelet count remain within the normal range, but her aPL are still present.

Article Published Date : Mar 31, 2016
Category: Vaccination: All
Vaccination: All, Autoimmune Diseases, Thrombocytopenia, Molecular Mimicry, Human: Case Report, Vaccination: HPV (Gardasil)